Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones.

Ena, J; López-Perezagua, M M; Martínez-Peinado, C; Cia-Barrio, M A; Ruíz-López, I

Ena, J; López-Perezagua, M M; Martínez-Peinado, C; Cia-Barrio, M A; Ruíz-López, I.

Affiliation

Ena J; Internal Medicine Division, Hospital Marina Baixa, Villajoyosa, Alicante, Spain.

Diagn Microbiol Infect Dis ; 30(2): 103-7, 1998 Feb.

Article in En | MEDLINE | ID: mdl-9554177

Subject(s)

Anti-Bacterial Agents/therapeutic use; Ciprofloxacin/therapeutic use; Escherichia coli/isolation & purification; Aged; Contraindications; Drug Resistance, Microbial; Drug Utilization; Humans; Linear Models; Norfloxacin/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Ciprofloxacin / Escherichia coli / Anti-Bacterial Agents Language: En Journal: Diagn Microbiol Infect Dis Year: 1998 Type: Article Affiliation country: Spain

Search on Google

Add to My VHL

XML

PubMed Links